Sinofn Health
Sinofn Health
In an era where preventative healthcare is paramount, the global nutraceutical and pharmaceutical landscape is undergoing a paradigm shift. Consumers are no longer satisfied with generic, mass-produced vitamins; they demand precision, personalization, and clinical transparency. SINOFN Health Nutraceuticals Pharmaceuticals, as a premier manufacturer and supplier, sits at the intersection of this evolution.
The market for Foods for Special Medical Purposes (FSMP) and functional nutraceuticals is expanding at an unprecedented rate. Factors such as aging populations, the rising prevalence of metabolic disorders, and an increasing public awareness of gut health and cognitive enhancement are driving demand. SINOFN leverages its partnership with the Chinese Academy of Sciences to translate complex biochemical research into scalable industrial solutions.
Our operational philosophy is built on three pillars: Clinical Rigor, Regulatory Compliance, and Scalable Innovation.
With our Tianjin R&D center, we focus on bioavailability optimization. We don't just manufacture; we engineer delivery systems that maximize efficacy.
Navigating global compliance (FDA, EU EFSA, HALAL) is complex. We provide full documentation support to ensure your product reaches the shelf without friction.
From micro-batch pilot runs for startups to massive industrial scale-up, our 10+ GMP production lines ensure quality consistency across all quantities.
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group – a national high-tech enterprise founded in 2012 and backed by the Chinese Academy of Sciences. Established in 2025, we operate from Shanghai as the trading hub for global partners seeking premium, science-driven contract manufacturing services.
GuoHong Liu: During her clinical work, Mrs. Liu witnessed lifelong struggles of PKU (Phenylketonuria) children – where specialized diets were financially out of reach. Driven to bridge this gap, she founded SINOFN in 2012 to develop affordable, science-backed PKU foods.
Her commitment includes: Profit with Purpose, where we dedicate a portion of revenues to PKU accessibility initiatives, and an unwavering R&D legacy built through deep academic collaboration.
Medical Innovation Director, Ph.D Peking University Medical School. 15+ years in metabolic disorder formulations.
R&D Lead, Associate Researcher, CAS Postdoc. Specialist in bioactive compound delivery systems.
Formulation Director, Senior Scientist (Netherlands). EU regulatory specialist in nutraceutical delivery tech.
Our team includes doctoral candidates, master's candidates, and specialized lab technicians ensuring every product meets global standards.
We understand that a product successful in one market may face regulatory hurdles in another. SINOFN provides Global Regulatory Alignment. Whether it is strict labeling requirements in the European Union or specific FDA filing assistance in the United States, our regulatory team acts as an extension of your own department. We bridge the gap between Chinese high-tech manufacturing and Western market compliance standards.
Our roadmap involves increasing investments in Biotech-Enhanced Nutraceuticals. We are currently scaling our capabilities in:
Our operations are centered in high-tech manufacturing hubs in China, with Shanghai serving as our global trade gateway for efficient logistics and communication.
Absolutely. We offer pilot-scale production lines specifically designed for testing formulations before full commercial rollout, minimizing your market entry risk.
Yes. Our modular production lines allow us to tailor scope and MOQ (Minimum Order Quantity) for both emerging brands and established global pharmaceutical entities.
